News > Article
Alzheimer's Disease Research
BrightFocus Foundation recently hosted a live Instagram conversation featuring Alzheimer’s Disease Research grantee Dr. Keith Hengen, Washington University School of Medicine, and BrightFocus Foundation’s Dr. Sharyn Rossi.
Dr. Hengen discussed his groundbreaking research on how early-life disruptions in brain networks may predict future neurodegeneration—work that uses mathematical modeling to unlock new insights into Alzheimer’s disease.
They also discussed the connection between sleep and brain health and actions you can take to protect brain health. Watch the full conversation below and read more about Dr. Hengen’s Alzheimer’s Disease Research-funded work.
About BrightFocus Foundation
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
- Research Spotlight
News
Related Articles and Information
Article
Targeting Genetic Triggers of Inflammation in Alzheimer’s Disease
A BrightFocus Alzheimer’s Disease Research-funded scientist is investigating how “jumping genes” may fuel brain inflammation in Alzheimer’s—and whether blocking them could prevent or slow dementia.
Article
Home-Based Alzheimer’s Treatment Brings Care Closer to Families
A team of BrightFocus Alzheimer’s Disease Research-funded scientists is exploring how home-based brain stimulation could improve memory, mood, and daily life for people living with Alzheimer’s disease.
Article
The Early Alzheimer’s Signals We’ve Been Missing (Until Now)
Using advanced genetic sequencing, BrightFocus Alzheimer’s Disease Research-funded scientist Dr. Mark Ebbert is identifying overlooked changes in the brain that could finally unlock a way to diagnose Alzheimer’s before it begins.
Article
New Blood Test Could Personalize Alzheimer’s Treatment Like Never Before
A new Alzheimer’s blood test may reveal how far the disease has progressed and identify who’s most likely to benefit from anti-amyloid therapies.
